Robert Dishman

Robert A. Dishman was the founder of Serenex, Inc. (founded in 2000) where he held the title of Chief Executive Officer & Director from 2000 to 2002, and BioFlash Partners LLC (founded in 2007) where he held the title of Director from 2011 to 2012.
Currently, he is the President & Chief Executive Officer at Molecular Recognition, Inc. since 2002.
Previously, he worked as Director & Executive Vice President at Dyax Corp.
from 1994 to 2000.
He also served as an Independent Director at Harvard Bioscience, Inc. from 2000 to 2015.
Additionally, he held positions as Director at BioSystem Development LLC, Tarpon Biosystems, Inc., and Advisor at Echelon Ventures.
He was also the Executive Vice President-Supply Chain at Nextlife, Inc. Dr. Dishman earned a doctorate degree from the University of Massachusetts and an undergraduate degree from the University of New Hampshire.